May 2008
Volume 49, Issue 13
ARVO Annual Meeting Abstract  |   May 2008
Inhibition of Neutrophil Migration in the Injured Murine Cornea by Mmp-2/9 Blockade
Author Affiliations & Notes
  • E. J. Lee
    Oregon Health & Science Univ, Portland, Oregon
    Casey Eye Institute,
  • G. D. Scott
    Oregon Health & Science Univ, Portland, Oregon
    Casey Eye Institute,,
  • J. T. Rosenbaum
    Oregon Health & Science Univ, Portland, Oregon
    Casey Eye Institute,,
  • S. R. Planck
    Oregon Health & Science Univ, Portland, Oregon
    Casey Eye Institute,,
  • Footnotes
    Commercial Relationships  E.J. Lee, None; G.D. Scott, None; J.T. Rosenbaum, None; S.R. Planck, None.
  • Footnotes
    Support  NIH Grant EY015448 (EJL), Research to Prevent Blindness Awards (JTR, TMM, SRP, CEI)
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 2388. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E. J. Lee, G. D. Scott, J. T. Rosenbaum, S. R. Planck; Inhibition of Neutrophil Migration in the Injured Murine Cornea by Mmp-2/9 Blockade. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2388.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Matrix metalloproteinases-2 and -9 (gelatinases A and B, MMP-2/9) are produced by leukocytes to degrade extracellular matrix components and may facilitate cell migration in the inflamed cornea. We examined the role of MMP-2/9 in neutrophil trafficking using a synthetic inhibitor or the antibiotic doxycycline, which also inhibits MMP activity and synthesis.

Methods: : Mice expressing enhanced green fluorescent protein (eGFP) in the lysozyme M locus were used to visualize neutrophils following silver nitrate injury to the central cornea. At 5 h after injury, eyes received: 1) PBS, 2) MMP-2/9 inhibitor III (MMPi, 6 µg in 6 µl)(Calbiochem), or 3) doxycycline hyclate (60 µg in 6 µl). Doses were split between temporal subconjunctival and central corneal stroma injections.Corneas were dissected for ex vivo examination 1 h post-treatment to determine eGFP+ cell density in sectors adjacent to and opposite the injection site (n=4/group). Cell migration was recorded by in vivo videomicroscopy just before and at 1 h after treatment. Randomly selected cells were tracked and analyzed.

Results: : Asymmetric distribution of neutrophils in MMPi- and doxycycline-treated, but not PBS-treated, corneas suggests a local effect on neutrophil migration. In the corneal sector adjacent to the subconjunctival injection there were significantly fewer cells in doxycycline-treated corneas in both the periphery (within 100 µm internal to limbal vessel)(p=0.047) and mid-periphery (~600 µm internal to limbal vessel)(p=0.048) when compared to PBS-treated controls. There was a similar decrease in cells in MMPi-treated corneas in the mid-periphery (p=0.048), but not in the periphery (p=0.886). Cells near the inhibitor injection site exhibited decreased speed compared to PBS controls. Before treatment, eGFP+ cells in the cornea (113 cells, 12 corneas) traveled at a lateral speed of 6.6±0.4 µm/min (median±SEM). Treatment with MMPi reduced speeds to 3.6±0.9 µm/min (p=0.019 vs. pre-treatment) and with doxycycline to 2.4±0.9 µm/min (p=0.002) compared to 7.9±1.0 µm/min with PBS (p=0.731 vs. pre-treatment).

Conclusions: : Treatment with either MMP-2/9 inhibitor or doxycycline reduced neutrophil migration through tissue stroma. Additionally, doxycycline treatment affected neutrophil entry into the corneal periphery.

Keywords: inflammation • cornea: basic science • imaging/image analysis: non-clinical 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.